HEALTHCARE2/27/2026 • LIVE

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY) is a healthcare company operating in drug manufacturers—general. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. This analysis page tracks valuation context, trend strength, and downside risk over time.

PRICE
$1022.02
-0.66% today
RISK
VERY HIGH

Key Metrics

MARKET CAP
$964.13B
P/E RATIO
44.4
BETA
0.39
Less volatile
DIV YIELD
0.61%
52W HIGH
$1133.95
52W LOW
$623.78
VOLATILITY
54.1%
30d annualized

Price Performance

30-DAY PRICE CHART

$1039.51 → $1022.02-1.68%
30 days agoToday

1-YEAR PERFORMANCE

$920.63 → $1022.02+11.0%
$729$864$999FebMarAprMayJunJulAugSepOctNovDecJan
LLY | 52-week chartLast updated: 2/27/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRICLLYSECTOR AVGVS SECTOR
P/E Ratio44.4x22.0x 102%
Beta0.390.85Less volatile
Div Yield0.61%1.50%Below avg
30d Volatility54.1%22%Higher risk

TOP HEALTHCARE PEERS

Competitors Analysis

Compare LLY's key metrics against its main healthcare sector competitors.

COMPANYPRICEMARKET CAPSECTOR
LLY(You are here)
$1022.02$964.13BHealthcare
UNH$286.66$259.67BHealthcareVIEW →
JNJ$243.47$586.74BHealthcareVIEW →
PFE$27.10$154.08BHealthcareVIEW →
Click on a competitor to view their full analysis

Technical Analysis

Eli Lilly and Company is currently trading at $1022.02, which is 9.9% below its 52-week high. With a beta of 0.39, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL
30-DAY TRENDNEUTRAL
VOLUME2.1M(Below avg)

Frequently Asked Questions

Is LLY a good buy right now?

Eli Lilly and Company trades at 44.4x earnings. This is above market average, reflecting growth expectations. Current risk level is Very High based on 54.1% volatility.

Does LLY pay dividends?

Yes, Eli Lilly and Company offers a dividend yield of 0.61%. This translates to approximately $6.23 per share annually.

How volatile is LLY?

With 30-day annualized volatility of 54.1% and beta of 0.39,LLY is classified as Very High risk. The stock tends to be more stable than the market average.

Related Assets

Track LLY Live

Add Eli Lilly and Company to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL
Last updated: 2/27/2026, 2:03:30 PM